Division of Infectious Diseases & International Health, Department of Medicine, University of Virginiagrid.27755.32, Charlottesville, Virginia, USA.
Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0083222. doi: 10.1128/aac.00832-22. Epub 2022 Oct 18.
New anti-Entamoeba histolytica multistage drugs are needed because only one drug class, nitroimidazoles, is available for treating invasive disease, and it does not effectively eradicate the infective cyst stage. Zinc ditiocarb (ZnDTC), a main metabolite of the FDA-approved drug disulfiram, was recently shown to be highly effective against the invasive trophozoite stage. In this brief report, we show that ZnDTC is active against cysts, with similar potency to first-line cysticidal drug paromomycin.
需要新的抗溶组织内阿米巴多阶段药物,因为目前仅有一类药物,即硝基咪唑类,可用于治疗侵袭性疾病,而且不能有效消除感染性囊型阶段。锌二硫代氨基甲酸盐(ZnDTC)是美国食品和药物管理局批准的药物双硫仑的主要代谢物,最近被证明对侵袭性滋养体阶段非常有效。在本简要报告中,我们表明 ZnDTC 对囊型阶段具有活性,与一线囊虫药物巴龙霉素的效力相当。